New Jazz Pharmaceuticals Quality Improvement Grant Opportunity for HER2+ Gastroesophageal Adenocarcinoma and Glioma – Conquer Cancer
Conquer Cancer, the ASCO Foundation/ LinkedIn

New Jazz Pharmaceuticals Quality Improvement Grant Opportunity for HER2+ Gastroesophageal Adenocarcinoma and Glioma – Conquer Cancer

Conquer Cancer, the ASCO Foundation shared on LinkedIn:

“Applications due October 15!

A new Jazz Pharmaceuticals Quality Improvement Grants opportunity, powered by Conquer Cancer’s EveryGrant, is now accepting applications!

This grant will provide funding for projects that will improve care for HER2+ Gastroesophageal Adenocarcinoma and Glioma.

Apply today!”

GEA: Gastroesophageal Adenocarcinoma (GEA) Quality Improvement Grant (Jazz Pharmaceuticals)

Glioma: Glioma Quality Improvement Grant (Jazz Pharmaceuticals).”

Other articles about Conquer Cancer, the ASCO Foundation on OncoDaily.